2022年9月28日 · What is small cell lung cancer? Small cell lung cancer is a rare fast-growing lung cancer. Small cell lung cancer can affect anyone, but it typically affects people who have a long history of tobacco use, specifically smoking cigarettes.

2021年3月5日 · SCLC is a very aggressive form of cancer that often goes undiagnosed until it’s more advanced, so the survival rate tends to be low. However, if the cancer is detected in its early stages, the...

Small-cell carcinoma, also known as oat cell carcinoma, is a type of highly malignant cancer that most commonly arises within the lung, [1] although it can occasionally arise in other body sites, such as the cervix, [2] prostate, [3] and gastrointestinal tract.

Learn how different stages of small cell lung cancer are treated. Treatment options include chemotherapy, radiation therapy, and immunotherapy.

Small cell lung cancer treatment options include surgery, chemotherapy and radiation therapy, laser therapy, targeted therapy, and supportive care. Learn more about treatments for newly diagnosed and recurrent small cell lung cancer in this expert-reviewed summary.

After someone is diagnosed with small cell lung cancer (SCLC), doctors will try to figure out if it has spread, and if so, how far. This process is called staging. The stage of a cancer describes where the cancer is in the body. It helps determine how best to treat it. Doctors also use a cancer’s stage when talking about survival statistics.

2023年7月10日 · Lung cancer is histologically divided into 2 main types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC comprises about 15% of lung cancer while NSCLC comprises approximately 85%.

SCLC is an aggressive neoplasm characterized by rapid proliferation, early dissemination, metastases, acquired therapy resistance, and poor outcomes [3]. Each year, approximately 250,000 new cases of SCLC are reported, resulting in at least 200,000 deaths worldwide [1].

2 天之前 · Small cell lung cancer (SCLC) is an aggressive malignancy characterized by rapid proliferation and high metastatic potential. It is characterized by universal inactivation of and RB1, overexpression of the MYC family and dysregulation of multiple oncogenic signaling pathways. Among different patients, SCLCs are similar at the genetic level but exhibit significant …

2025年3月26日 · SCLC accounts for approximately 15% of bronchogenic carcinomas. At the time of diagnosis, approximately 30% of patients with SCLC have tumors confined to the hemithorax of origin, mediastinum, or supraclavicular lymph nodes. These patients have …